GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (HKSE:02607) » Definitions » ROE % Adjusted to Book Value

Shanghai Pharmaceuticals Holding Co (HKSE:02607) ROE % Adjusted to Book Value : 16.13% (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co ROE % Adjusted to Book Value?

Shanghai Pharmaceuticals Holding Co's ROE % for the quarter that ended in Mar. 2024 was 8.87%. Shanghai Pharmaceuticals Holding Co's PB Ratio for the quarter that ended in Mar. 2024 was 0.55. Shanghai Pharmaceuticals Holding Co's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was 16.13%.


Shanghai Pharmaceuticals Holding Co ROE % Adjusted to Book Value Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co ROE % Adjusted to Book Value Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.77 14.79 15.60 14.48 9.82

Shanghai Pharmaceuticals Holding Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.10 8.08 11.16 -0.30 16.13

Competitive Comparison of Shanghai Pharmaceuticals Holding Co's ROE % Adjusted to Book Value

For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Pharmaceuticals Holding Co's ROE % Adjusted to Book Value Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's ROE % Adjusted to Book Value falls into.



Shanghai Pharmaceuticals Holding Co ROE % Adjusted to Book Value Calculation

Shanghai Pharmaceuticals Holding Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=5.50% / 0.56
=9.82%

Shanghai Pharmaceuticals Holding Co's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=8.87% / 0.55
=16.13%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Pharmaceuticals Holding Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Shanghai Pharmaceuticals Holding Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Pharmaceuticals Holding Co (HKSE:02607) Business Description

Traded in Other Exchanges
Address
No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals Holding is a vertically integrated Chinese healthcare company that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the second-largest distributor by revenue and has a strong distribution presence in Eastern China.
Executives
Blackrock, Inc. 2201 Interest of corporation controlled by you
Shanghai Industrial Investment (holdings) Company Limited 2201 Interest of corporation controlled by you
Siic International Investment Company Limited 2101 Beneficial owner
Citigroup Inc. 2201 Interest of corporation controlled by you
Lsv Asset Management 2102 Investment manager

Shanghai Pharmaceuticals Holding Co (HKSE:02607) Headlines

No Headlines